Abstract LB168: A selective, potent, and orally bioavailable CDK7 inhibitor demonstrates superior anti-cancer activity in colorectal cancer models
Park, Heuijoon, Seo, Kyoungwan, Yu, Jihyun, Kim, Jieun, Joo, Min Sung, Kim, Sungeun, Lee, Joonhyung, Lee, Jeonghyeon, Kim, Eun-Jung, Nam, Joonwoo, Han, Wooseok
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Abstract 5006: Discovery of novel heterobifunctional degraders of mutant EGFR proteins for NSCLCs harboring various EGFR mutations
Ki, Dong Hyuk, Joo, Min Sung, Nam, Joonwoo, Choi, Hunmi, Seo, Kyoungwan, Kim, Eun-Jung, Kim, Jiyeon, Kim, Chulwon, Jin, Jimmy Taiguang, Han, Wooseok
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article